Dr. Xia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1441 Eastlake Ave
NOR 7416
Los Angeles, CA 90033Phone+1 323-865-3700- Is this information wrong?
Summary
- Email: Leilei.Xia@med.usc.edu
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Urologic Surgical Oncology, 2023 - 2025
University of Pennsylvania Health SystemResidency, Urology, 2018 - 2023
Anhui Medical UniversityClass of 2012
Certifications & Licensure
CA State Medical License 2023 - 2025
PA State Medical License 2018 - 2023
Publications & Presentations
PubMed
- 45 citationsMicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5.Tianyuan Xu, Liang Qin, Zhaowei Zhu, Xianjin Wang, Yue Liu
Oncotarget. 2016-03-30 - 16 citationsSurgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer.Leilei Xia, Ruchika Talwar, Raju R. Chelluri, Thomas J. Guzzo, Daniel J. Lee
JAMA Network Open. 2020-12-01 - 4 citationsSurvival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer.Christopher Corbett, Leilei Xia, Ronac Mamtani, S.B. Malkowicz, Thomas J. Guzzo
Urology. 2019-06-11
Journal Articles
- Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate CancerLeilei Xia, Ruchika Talwar, JAMA Network Open
Press Mentions
Safety of Delaying Surgery for High-Risk Prostate CancerDecember 8th, 2020- Safety of Delaying Surgery for High-Risk Prostate CancerDecember 8th, 2020
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
